EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Risk factors for persistent decline in eGFR of Japanese patients with diabetes: Analysis using a large‐scale diabetes registry J‐ DREAMS

Kota Yamada iD, Mitsuru Ohsugi iD, Yuichiro Ito iD, Hiroki Uchida iD, Takumi Lee iD, Kohjiro Ueki iD

Journal of Diabetes Investigation · 2026

DOI: 10.1111/jdi.70214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Investigation, 2026. Verfasst von Kota Yamada und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine (Currently National Center for Global Health and…. Hauptthemen laut MEDLINE: Glomerular Filtration Rate, Diabetic Nephropathies, Diabetes Mellitus, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Health, Labour and Welfare, Japan Agency for Medical Research and Development, Astellas Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/Introduction This study aimed to identify clinical predictors associated with sustained decline in estimated glomerular filtration rate (eGFR) among Japanese individuals diagnosed with diabetes mellitus. Materials and Methods We conducted a retrospective analysis using J‐DREAMS (Japan Diabetes compREhensive database project based on an Advanced Electronic Medical record System), a large‐scale registry integrated with electronic medical records. The study population included adults (≥18 years) with diabetes who had at least one documented visit at a referral institution between December 1, 2015, and March 31, 2021, with concurrent measurements of serum creatinine and hemoglobin.

Results

A total of 12,416 and 11,157 patients were eligible for assessment of eGFR change at 1 and 2 years, respectively. Multivariable logistic regression identified several consistent risk factors for ≥30% eGFR reduction at both time points: low serum albumin, elevated triglycerides, anemia as defined by JSDT, diabetic retinopathy, CKD Stage G4 or higher, albuminuria category A3, and chronic heart failure. Additional predictors at 1 year included age under 65 and elevated HbA1c, while smoking, hypertension, and diabetic neuropathy were significant only at 2 years.

Conclusion

Beyond retinopathy and advanced kidney disease, anemia, hypoalbuminemia, and heart failure independently contributed to persistent eGFR decline, supporting the clinical relevance of cardio‐renal anemia syndrome in diabetic populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerular Filtration RateDiabetic NephropathiesDiabetes MellitusRenal Insufficiency, ChronicHumansMaleFemaleMiddle AgedRegistriesRisk FactorsRetrospective StudiesAgedJapanAdultGlycated HemoglobinPrognosisFollow-Up StudiesEast Asian People

Stichwörter der Autor:innen

Cardio‐renal anemia syndromeDiabetic kidney diseaseLow serum albumin

Substanzen

Glycated Hemoglobin

Autor:innen und Institutionen

  • Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine (Currently National Center for Global Health and Medicine, Japan Institute for Health Security), Center Hospital, Toya…
  • Department of Diabetes & Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
  • Diabetes and Metabolism Information Center, Research Institute, National Center for Global Health and Medicine (Currently National Institute for Global Health and Medicine, Japan Institute for Health Security), Toyama,…
  • Medical Affairs, Astellas Pharma Inc., Chuo-Ku, Tokyo, Japan.
  • Development, Astellas Pharma Inc., Chuo-Ku, Tokyo, Japan.
  • Diabetes Research Center, Research Institute, National Center for Global Health and Medicine (Currently National Institute for Global Health and Medicine, Japan Institute for Health Security), Toyama, Shinjuku-ku, Tokyo…

ORCID-Profile: Kota Yamada, Mitsuru Ohsugi, Yuichiro Ito, Hiroki Uchida, Takumi Lee, Kohjiro Ueki

Förderung

  • Ministry of Health, Labour and Welfare
  • Japan Agency for Medical Research and Development
  • Astellas Pharma

Zitieren

APA

Yamada, K., Ohsugi, M., Ito, Y., Uchida, H., Lee, T., & Ueki, K. (2026). Risk factors for persistent decline in eGFR of Japanese patients with diabetes: Analysis using a large‐scale diabetes registry J‐ DREAMS. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.70214

Vancouver

Yamada K, Ohsugi M, Ito Y, Uchida H, Lee T, Ueki K. Risk factors for persistent decline in eGFR of Japanese patients with diabetes: Analysis using a large‐scale diabetes registry J‐ DREAMS. Journal of Diabetes Investigation. 2026. doi:10.1111/jdi.70214

BibTeX
@article{Yamada2026,
  author = {Yamada, Kota and Ohsugi, Mitsuru and Ito, Yuichiro and Uchida, Hiroki and Lee, Takumi and Ueki, Kohjiro},
  title = {Risk factors for persistent decline in eGFR of Japanese patients with diabetes: Analysis using a large‐scale diabetes registry J‐ DREAMS},
  journal = {Journal of Diabetes Investigation},
  year = {2026},
  doi = {10.1111/jdi.70214}
}
Kostenlos starten →